The study from the Mayo Clinic discovered an interaction between the medication and the patients' genes.
Researchers say the genes help regulate brain chemicals controlling appetite, the same chemicals that are targeted by Meridia allowing the drug and the DNA to work together to increase weight loss. They say the findings give a glimpse into the future of personalized medicine, where the first medical test physicians give their patients may just be for DNA.
